Navigation Links
Best Practice Database: Complimentary Excerpt of Scientific Publications Strategy Study
Date:3/26/2008

CHAPEL HILL, N.C., March 26 /PRNewswire/ -- An article this week in The Wall Street Journal said Merck & Co. and Schering-Plough Corp. kept a study of their blockbuster drug Vytorin under wraps for more than a year because of data concerns. The article went on to say the study - which found Vytorin was no better than a generic - has renewed concern over the practice of selective publication.

As the debate continues over how pharma companies manage the scientific publications process, organizations are adjusting their publication operations, according to research from benchmarking leader Best Practices, LLC. For instance, some companies have shifted their global publications functions out of commercial and into medical operations, according to the study.

The study, Scientific Publications Strategy: Managing Reputation, Clinical Trial Results, is available in the Best Practice Database, an online resource that contains more than $35 million in proprietary research conducted on behalf of executives from Fortune 500 companies.

A complimentary excerpt of the publications study is available at http://www.best-in-class.com/dr292.htm .

The study illustrates how pharmaceutical companies are following a publishing strategy that presents all study findings while still driving brand strength through commercially relevant publications. Publishing leaders from pharma and biotech companies can use this research to evaluate the resources and strategies of their publication operations.

Key topic areas covered in the study include:

-- Global Publications Structure and Functional Home (Medical vs.

Marketing)

-- Key Contributors and Stakeholders in Strategy Development and Plan

Delivery

-- Effective Publications Vehicles, Content and Audiences

-- Using Alternative Media

-- Planning for Neutral/Negative Results

-- Changes in Resources and Outsourcing

-- Measuring Performance

-- Strategic Next Steps

For more information, contact Jeff Zimmer, Senior Research Analyst, at 919-767-9180 or at jzimmer@best-in-class.com. To access the full report or download a complimentary copy of the report summary, go to http://www3.best-in-class.com/dr292.htm .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class organizations. For more information, call 919-403-0251 or visit http://www.best-in-class.com .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. American Specialty Health and INSPIRIS Win Top Honors in URACs Best Practices in Consumer Empowerment and Protection Awards
2. Multi-site Gastro Practice Chooses Intergy by Sage Practice Management System
3. Winners of Best Practices in Consumer Empowerment and Protection Awards to be Announced at Conference
4. ACP to develop quality improvement tools to support internal medicine practice changes
5. Burgerville Honored for Dedication to Employees and Innovative Workplace Practices
6. Part-Time Practice Trends Intensify Physician Shortage According to AMGA and Cejka Search 2007 Physician Retention Survey
7. Kidney cancer surgery often determined by surgeons practice style, not medical factors
8. Raintree Systems Launches the First Integrated Practice Management and Electronic Medical Records Application Within the Bariatric Surgery Industry
9. AANA Condemns Unsafe Injection Practices
10. Anthem Blue Cross and Blue Shield Acts to Support Las Vegans Impacted by Endoscopy Center Practices
11. Attention New York: Please Dont Get Sick on March 4th, Your Doctor Will be in Albany for Malpractice Insurance Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... mass and overall body strength, which often leads to a host of health ... Journal of the American Geriatrics Society discovered that good overall muscle strength ...
(Date:2/27/2017)... ... February 27, 2017 , ... Robert E. Burke, MD, PhD, had ... his impoverished upbringing and life experiences could have led him down a much different ... Inspirational Tales of Parenting, Perseverance and Pediatrics,” Dr. Burke shares a personal account of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Much attention has ... for women who become dependent on opioid painkillers has fallen short. From 1999 until ... to a 237% increase in fatal overdoses in male populations.(1) , The proportion of ...
(Date:2/27/2017)... , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your typical author. ... studying to become a nun. Now, she writes about God, when she isn’t swimming as ... BC and AD, Here is BS! (Before Satan),” she offers a comedic look at the ...
(Date:2/27/2017)... Yorba Linda, Ca (PRWEB) , ... February 27, ... ... Coulter Life Sciences, provides an overview on laser diffraction analysis as a tool ... highlighting its capabilities, significance and potential to obtain improved results and novel scientific ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... YORK , Feb. 27, 2017 /PRNewswire/ ... Michael P. Vallely , MBBS, PhD, FRACS, of  ... University of Sydney will be published ...  Journal of the American College of Cardiology ... "no-touch" beating heart bypass surgery technique (anOPCABG) ...
(Date:2/27/2017)... Feb. 27, 2017  International Biophysics Corporation, a global medical ... today announced a 34% revenue growth in 2016 when compared ... unit sales.  This growth was fueled by its AffloVest® sales ... to the expansion of its global sales of surgical product ... CEO, "As we enter our 25 th year in ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
Breaking Medicine Technology: